Publication: Past, present, and future of therapies for pituitary neuroendocrine tumors: need for omics and drug repositioning guidance
No Thumbnail Available
Date
2022-03-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Innovation roadmaps are important, because they encourage the actors in an innovation ecosystem to creatively imagine multiple possible science future(s), while anticipating the prospects and challenges on the innovation trajectory. In this overarching context, this expert review highlights the present unmet need for therapeutic innovations for pituitary neuroendocrine tumors (PitNETs), also known as pituitary adenomas. Although there are many drugs used in practice to treat PitNETs, many of these drugs can have negative side effects and show highly variable outcomes in terms of overall recovery. Building innovation roadmaps for PitNETs\" treatments can allow incorporation of systems biology approaches to bring about insights at multiple levels of cell biology, from genes to proteins to metabolites. Using the systems biology techniques, it will then be possible to offer potential therapeutic strategies for the convergence of preventive approaches and patient-centered disease treatment. Here, we first provide a comprehensive overview of the molecular subtypes of PitNETs and therapeutics for these tumors from the past to the present. We then discuss examples of clinical trials and drug repositioning studies and how multi-omics studies can help in discovery and rational development of new therapeutics for PitNETs. Finally, this expert review offers new public health and personalized medicine approaches on cases that are refractory to conventional treatment or recur despite currently used surgical and/or drug therapy.
Description
Keywords
Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, Tıbbi Genetik, Yaşam Bilimleri, Biyoteknoloji, Moleküler Biyoloji ve Genetik, Temel Bilimler, Medicine, Health Sciences, Internal Medicine Sciences, Medical Genetics, Life Sciences, Biotechnology, Molecular Biology and Genetics, Natural Sciences, BİYOTEKNOLOJİ VE UYGULAMALI MİKROBİYOLOJİ, Mikrobiyoloji, Yaşam Bilimleri (LIFE), GENETİK VE KALITIM, Moleküler Biyoloji ve Genetik, BIOTECHNOLOGY & APPLIED MICROBIOLOGY, MICROBIOLOGY, Life Sciences (LIFE), GENETICS & HEREDITY, MOLECULAR BIOLOGY & GENETICS, Genetics, Molecular Biology, Applied Microbiology and Biotechnology, Molecular Medicine, Genetics (clinical), pituitary neuroendocrine tumors, pituitary adenoma, systems medicine, drug repositioning, omics, personalized medicine, GLUCOCORTICOID-RECEPTOR ANTAGONIST, LONG-TERM TREATMENT, LOW-DOSE ETOMIDATE, CUSHINGS-SYNDROME, GROWTH-HORMONE, MEDICAL-TREATMENT, EUROPEAN-SOCIETY, ADENOMAS, DISEASE, MANAGEMENT
Citation
Aydin B., Yildirim E., ERDOĞAN O., ARĞA K. Y., Yilmaz B., BOZKURT S., BAYRAKLI F., TURANLI B., "Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance", OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, cilt.26, sa.3, ss.115-129, 2022